Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants

3 doses, intramuscular (IM) route, in left antero-lateral thigh, as follows: 1) RTS,S Neo-10-14 Group at less than (=\<) 7 days, at 10 and 14 weeks (wks) of age; 2) RTS,S Neo-10-26 Group =\< 7 days, at 10 and 26 wks of age; 3) RTS,S 6-10-14 Group at 6, 10 and 14 wks of age; 4) RTS,S 6-10-26 Group at 6, 10 and 26 wks of age; 5) Engerix-B Neo/RTS,S 6-10-26 Group at 6, 10 and 26 wks of age; 6) RTS,S 10-14-26 Group at 10, 14 and 26 wks of age; 7) RTS,S 14-26-9M Group at 14 and 26 wks of age and at 9 months of age

1 dose, intramuscular route: left antero-lateral thigh at birth (=\< 7 days of age)

3 doses, intramuscular route: right antero-lateral thigh at 6, 10 and 14 weeks of age

1 dose, intradermal route, in shoulder at birth (=\< 7 days of age)

4 doses, orally, at birth (=\< 7 days of age) and at 6, 10 and 14 weeks of age

1 dose, intramuscular (IM) route, in left antero-lateral thigh, at 9 months of age